| Financial Year |
March 31 2023 |
| Monetary Funds |
1,136,459,641.89 |
| Held-for-trading Financial Assets |
86,784,200.00 |
| Notes Receivable |
8,567,673.48 |
| Accounts Receivable |
118,495,542.03 |
| Advances to Suppliers |
111,534,378.52 |
| Other Receivables |
274,626,758.62 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,784,013,118.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
94,404,734.80 |
| Total Current Assets |
3,614,886,047.98 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
236,370,388.06 |
| Investment Properties |
1,496,335,856.23 |
| Fixed Assetes |
327,436,519.79 |
| Under-construction Projects |
2,439,536.91 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
13,260,107.59 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
29,390,448.07 |
| Deferred Income Tax Assets |
112,573,563.74 |
| Other Non-Current Assets |
15,584.18 |
| Sub-Total of Non-Current Assets |
2,228,057,111.03 |
| Total Assets |
5,842,943,159.01 |
| Short-Term Loans |
212,260,498.45 |
| Trading Financial liabilities |
-- |
| Notes Payable |
60,357,462.27 |
| Accounts Payable |
363,335,827.64 |
| Accounts Received In Advance |
1,810,176.64 |
| Employee Compensation Payable |
37,410,023.10 |
| Taxes Payable |
103,977,284.39 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
380,148,150.02 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
175,825,342.37 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
1,733,031,292.30 |
| Long-term Loans |
365,656,219.34 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
102,658,747.04 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
477,000,189.77 |
| Total Liabilities |
2,210,031,482.07 |
| Paid-In Capital(Or Share Stock) |
310,880,000.00 |
| Capital Surplus |
143,567,263.83 |
| Surplus Reserve |
362,120,812.68 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,447,842,144.21 |
| Minority Stockholder's Interest |
367,016,841.88 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,265,894,835.06 |
| Owner's Equity（Stockholder's Equity） |
3,632,911,676.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,842,943,159.01 |
